How AI is changing healthcare

• Published in: Managed Healthcare Executive Vol. 34; no. 10; pp. 14 - 18
• Main Author: Kaltwasser, Jared
• Format: Trade Publication Article
• Language: English
• Published: Monmouth Junction MultiMedia Healthcare Inc 01.10.2024
• Subjects: Artificial intelligence; Clinical trials; Drug development; Efficiency; Health care; Health care industry; Health care policy; Large language models; Patients; Pharmaceutical industry; Ultrasonic imaging; United States > US
• ISSN: 1533-9300

Barinder Marhok, M.Pharm., global head of life sciences at Quantiphi, a digital engineering rm headquartered in suburban Boston, says one ripe opportunity to streamline health systems' efficiency is the mundane problems with scheduling patients. BenevolentAI's platform, and others like it, can identify potential molecules and targets that are likely to have a meaningful clinical effect, she says. [...]AI can then conduct simulations to help developers choose compounds to study in trials. According to a review article published in the journal Drug Discovery in June 2024, 67 AI-discovered molecules were being assessed in clinical trials in 2023, up from just seven in 2018. [...]molecular biology is just embedded in everything we do and how we think," she says. Since AI can better analyze things like the pathogenesis of diseases, she envisions a world where mechanisms become more important than disease categories.